A phase 1/2 clinical trial of AAV8 gene therapy in adults with late-onset OTC deficiency: CAPtivate cohort 1+2 results

被引：0
|
作者：
Geberhiwot, T. [1 ]
Aldamiz-Echevarria, L. [2 ]
Couce, M. L. [3 ]
Diaz, G. A. [4 ]
Harding, C. O. [5 ]
Khan, A. [6 ]
Tan, W. H. [7 ]
Lee, C. [8 ]
Puga, A. C. [8 ]
Crombez, E. [8 ]
机构：
[1] Univ Birmingham, Birmingham, W Midlands, England
[2] Cruces Univ Hosp, Biocruces Bizkaia Hlth Res Inst, Baracaldo, Spain
[3] Univ Santiago de Compostela, Santiago De Compostela, Spain
[4] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[5] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[6] Univ Calgary, Calgary, AB, Canada
[7] Harvard Med Sch, Boston Childrens Hosp, Boston, MA 02115 USA
[8] Ultragenyx Gene Therapy, Novato, CA USA
来源：
HUMAN GENE THERAPY | 2019年 / 30卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
OR49
引用
收藏
页码：A18 / A18
页数：1
相关论文
共 50 条
  • [31] AXO-AAV-GM2 Gene Therapy for Infantile- and Juvenile-onset GM2 Gangliosidosis: Preliminary Results from an Ongoing Phase 1/2 Trial
    Eichler, Florian
    Flotte, Terence
    Andonian, Haley
    Cataltepe, Oguz
    Artinian, Rebecca
    Misko, Albert
    Thorp, Benjamin
    Jameson, John
    Sheehan, Michael
    Vaughn, Toby
    Valencia, Donna
    De Boever, Erika
    MOLECULAR THERAPY, 2022, 30 (05) : 6 - 7
  • [32] A phase 1/2 trial of AXO-AAV-GM1 gene therapy for the treatment of infantile- and juvenile-onset GM1 gangliosidosis
    Tift, Cynthia
    D'Souza, Precilla
    Johnston, Jean
    Acosta, Maria
    Nicoli, Elena-Raluca
    Rothermel, Caroline
    Thurm, Audrey
    Karunakara, Ajith
    Thorp, Benjamin
    Ross, Peter
    Jameson, John
    Sheehan, Michael
    Vaughn, Toby
    Valencia, Donna
    De Boever, Erika
    GENETICS IN MEDICINE, 2022, 24 (03) : S164 - S164
  • [33] Phase 1/2 Trial of AXO-AAV-GM1 Gene Therapy for the Treatment of Infantile- and Juvenile-onset GM1 Gangliosidosis
    Tifft, C.
    D'Souza, P.
    Johnston, J. M.
    Acosta, M. T.
    Nicoli, E. R.
    Rothermel, C.
    Thurm, A.
    Karunakara, A.
    Thorp, B.
    Ross, P.
    Jameson, J.
    Sheehan, M.
    Vaughn, T.
    Valencia, D.
    De Boever, E.
    Corcoran, G.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A11 - A12
  • [34] Update on a phase 1/2 open-label trial of BAX335, an adeno-associated virus 8 (AAV8) vector-based gene therapy program for hemophilia B
    Monahan, P.
    Walsh, C. E.
    Powell, J. S.
    Konkle, B. A.
    Josephson, N. C.
    Escobar, M.
    McPhee, S. J.
    Litchev, B.
    Cecerle, M.
    Ewenstein, B. M.
    Rottensteiner, H.
    Rosa, M. D. L.
    Reipert, B. M.
    Samulski, R. J.
    Orloff, J.
    Scheiflinger, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 87 - 87
  • [35] Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial
    Joseph P. Casazza
    Evan M. Cale
    Sandeep Narpala
    Galina V. Yamshchikov
    Emily E. Coates
    Cynthia S. Hendel
    Laura Novik
    LaSonji A. Holman
    Alicia T. Widge
    Preeti Apte
    Ingelise Gordon
    Martin R. Gaudinski
    Michelle Conan-Cibotti
    Bob C. Lin
    Martha C. Nason
    Olga Trofymenko
    Shinyi Telscher
    Sarah H. Plummer
    Diane Wycuff
    William C. Adams
    Janardan P. Pandey
    Adrian McDermott
    Mario Roederer
    Avery N. Sukienik
    Sijy O’Dell
    Jason G. Gall
    Britta Flach
    Travis L. Terry
    Misook Choe
    Wei Shi
    Xuejun Chen
    Florence Kaltovich
    Kevin O. Saunders
    Judy A. Stein
    Nicole A. Doria-Rose
    Richard M. Schwartz
    Alejandro B. Balazs
    David Baltimore
    Gary J. Nabel
    Richard A. Koup
    Barney S. Graham
    Julie E. Ledgerwood
    John R. Mascola
    Nature Medicine, 2022, 28 : 1022 - 1030
  • [36] Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial
    Casazza, Joseph P.
    Cale, Evan M.
    Narpala, Sandeep
    Yamshchikov, Galina, V
    Coates, Emily E.
    Hendel, Cynthia S.
    Novik, Laura
    Holman, LaSonji A.
    Widge, Alicia T.
    Apte, Preeti
    Gordon, Ingelise
    Gaudinski, Martin R.
    Conan-Cibotti, Michelle
    Lin, Bob C.
    Nason, Martha C.
    Trofymenko, Olga
    Telscher, Shinyi
    Plummer, Sarah H.
    Wycuff, Diane
    Adams, William C.
    Pandey, Janardan P.
    McDermott, Adrian
    Roederer, Mario
    Sukienik, Avery N.
    O'Dell, Sijy
    Gall, Jason G.
    Flach, Britta
    Terry, Travis L.
    Choe, Misook
    Shi, Wei
    Chen, Xuejun
    Kaltovich, Florence
    Saunders, Kevin O.
    Stein, Judy A.
    Doria-Rose, Nicole A.
    Schwartz, Richard M.
    Balazs, Alejandro B.
    Baltimore, David
    Nabel, Gary J.
    Koup, Richard A.
    Graham, Barney S.
    Ledgerwood, Julie E.
    Mascola, John R.
    NATURE MEDICINE, 2022, 28 (05) : 1022 - +
  • [37] Neutralizing antibodies against AAV2, AAV5 and AAV8 in healthy and HIV-1-infected subjects in China: implications for gene therapy using AAV vectors
    Q Liu
    W Huang
    H Zhang
    Y Wang
    J Zhao
    A Song
    H Xie
    C Zhao
    D Gao
    Y Wang
    Gene Therapy, 2014, 21 : 732 - 738
  • [38] Clinical program to evaluate safety, preliminary efficacy, and dose selection of AAV8 gene therapy in patients with infantile and late onset Pompe disease (IOPD and LOPD)
    Rico, Salvador
    Schoser, Benedikt
    Dimmock, David
    Lawlor, Michael W.
    James, Emma
    Morton, Magda
    Prasad, Suyash
    MOLECULAR GENETICS AND METABOLISM, 2019, 126 (02) : S123 - S123
  • [39] Neutralizing antibodies against AAV2, AAV5 and AAV8 in healthy and HIV-1-infected subjects in China: implications for gene therapy using AAV vectors
    Liu, Q.
    Huang, W.
    Zhang, H.
    Wang, Y.
    Zhao, J.
    Song, A.
    Xie, H.
    Zhao, C.
    Gao, D.
    Wang, Y.
    GENE THERAPY, 2014, 21 (08) : 732 - 738
  • [40] Nutritional management in adults with glycogen storage disease type Ia (GSDIa) enrolled in a phase 1/2 clinical trial of an AAV8-mediated liver-directed gene therapy
    Saavedra, H.
    Mount, M.
    Lipinski, S.
    Camba-Garea, M-J
    de Boer, F.
    Reineking, B.
    Rodriguez-Buritica, D. F.
    Riba-Wolman, R.
    Ahmad, A.
    Couce Pico, M. L.
    Derks, T. G.
    Mitchell, J.
    Weinstein, D. A.
    Lee, C.
    Valayannopoulos, V.
    Crombez, E.
    MOLECULAR GENETICS AND METABOLISM, 2022, 136 : S19 - S19
12345